Probiotic cultures
AiBi® lyophilized concentrated probiotic cultures contain beneficial microflora in the amount of at least 1х1010 CFU/g. Clinically tested. By the end of shelf life, the finished product contains a minimum of 1×107 CFU/g of Lactobacillus and a minimum of 1×106 CFU/g of Bifidobacterium.
AiBi® Probiotic Cultures should be introduced under aseptic conditions into a tank with the milk mixture at the temperature of the product fermentation. AiBi® Probiotic Cultures ferment milk slowly, therefore they do not replace the primary starter, and are used as additional protective cultures.
Dosage
The dosage of AiBi® Probiotic Cultures is listed on the packaging: the contents of the packaging labeled "500 liters" should be introduced into 500 liters of the standardized milk mixture.
Packaging
Aseptic packaging.
| Name of the culture |
Microbiota content |
Characteristics |
|---|---|---|
| Probiline 6.10 probiotic culture |
Bifidobacterium bifidum, Bifidobacterium animalis ssp. lactis, Bifidobacterium longum ssp. longum. |
Target application Products helping to prevent gut dysbiosis |
| Probiline 3.10 probiotic culture |
Lactobacillus paracasei ssp. paracasei |
Target application Products of general prophylactic use (for the entire GI tract) |
| Probiline 6.10 MIX probiotic culture |
Bifidobacterium bifidum, Bifidobacterium animalis ssp. lactis, Bifidobacterium longum ssp. longum, Lactobacillus plantarum, Lactobacillus acidophilus, Lactobacillus paracasei ssp. paracasei, Lactobacillus rhamnosus |
Target application Products of complex prophylaxis use |
| Probiline 3.30 probiotic culture |
Lactobacillus plantarum |
Target application Products of complex prophylaxis use |
| Probiline 3.30 probiotic culture |
Lactobacillus rhamnosus |
Target application Products of general prophylactic use (for the entire GI tract) |